Document Detail


Inhibition of HMGB1 Enhances Bacterial Clearance and Protects against P. aeruginosa Pneumonia in Cystic Fibrosis.
MedLine Citation:
PMID:  22314397     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Pulmonary infection with Pseudomonas (P.) aeruginosa and neutrophilic lung inflammation significantly contribute to morbidity and mortality in cystic fibrosis (CF). HMGB1, a ubiquitous DNA binding protein that promotes inflammatory tissue injury, is significantly elevated in CF sputum. However, its mechanistic and potential therapeutic implications in CF were previously unknown. We found that HMGB1 levels were significantly elevated in bronchoalveolar lavage fluids (BAL) of CF patients and CFTR(-/-) mice. Neutralizing anti-HMGB1 mAb conferred significant protection against P. aeruginosa-induced neutrophil recruitment, lung injury and bacterial infection in both CFTR(-/-) and wildtype mice. Alveolar macrophages isolated from mice treated with anti-HMGB1 mAb had improved phagocytic activity, which was suppressed by direct exposure to HMGB1. In addition, BAL from CF patients significantly impaired macrophage phagocytotic function and this impairment was attenuated by HMGB1-neutralizing antibodies. The HMGB1-mediated suppression of bacterial phagocytosis was attenuated in macrophages lacking toll-like receptor 4 (TLR4), suggesting a critical role for TLR4 in signaling HMGB1-mediated macrophage dysfunction. These studies demonstrate that the elevated levels of HMGB1 in CF airways are critical for neutrophil recruitment and persistent presence of P. aeruginosa in the lung. Thus, HMGB1 may provide a therapeutic target for reducing bacterial infection and lung inflammation in CF.
Authors:
Maria Entezari; Daniel J Weiss; Ravikumar Sitapara; Laurie Whittaker; Matthew J Wargo; Jianhua Li; Haichao Wang; Huan Yang; Lokesh Sharma; Binh D Phan; Mohammad Javdan; Sangeeta S Chavan; Edmund J Miller; Kevin J Tracey; Lin L Mantell
Related Documents :
8627787 - Brucella abortus conjugated with a peptide derived from the v3 loop of human immunodefi...
8621927 - Binding and presentation of peptides derived from melanoma antigens mart-1 and glycopro...
12168827 - Helper peptide g89 (her-2:777-789) and g89-activated cells regulate the survival of eff...
11044257 - Cell death induction by ctl: perforin/granzyme b system dominantly acts for cell death ...
20647317 - Akt3-mediated resistance to apoptosis in b-raf-targeted melanoma cells.
6320857 - Chemiluminescence of asbestos-activated macrophages.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-2
Journal Detail:
Title:  Molecular medicine (Cambridge, Mass.)     Volume:  -     ISSN:  1528-3658     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9501023     Medline TA:  Mol Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Cardiopulmonary Toxicology, Department of Pharmaceutical Sciences, St. John's University College of Pharmacy and Allied Health Professions, Queens, NY 11439.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pediatric Obesity And Gallstone Disease: Results From A Cross-Sectional Study of Over 510,000 Youth...
Next Document:  Primary clavicle tumors and tumorous lesions: a review of 206 cases in East Asia.